These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure-DANISH-MRI. Elming MB; Hammer-Hansen S; Voges I; Nyktari E; Raja AA; Svendsen JH; Pehrson S; Signorovitch J; Køber L; Prasad SK; Thune JJ Am Heart J; 2020 Mar; 221():165-176. PubMed ID: 31955812 [TBL] [Abstract][Full Text] [Related]
14. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D. Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954 [TBL] [Abstract][Full Text] [Related]
16. Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD). Zhang Y; Kennedy R; Blasco-Colmenares E; Butcher B; Norgard S; Eldadah Z; Dickfeld T; Ellenbogen KA; Marine JE; Guallar E; Tomaselli GF; Cheng A Heart Rhythm; 2014 Aug; 11(8):1377-83. PubMed ID: 24793459 [TBL] [Abstract][Full Text] [Related]
17. Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Kusumoto FM; Bailey KR; Chaouki AS; Deshmukh AJ; Gautam S; Kim RJ; Kramer DB; Lambrakos LK; Nasser NH; Sorajja D J Am Coll Cardiol; 2018 Oct; 72(14):1653-1676. PubMed ID: 29097297 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and prognostic association of ventricular arrhythmia in non-ischaemic heart failure patients: results from the DANISH trial. Boas R; Thune JJ; Pehrson S; Køber L; Nielsen JC; Videbæk L; Haarbo J; Korup E; Bruun NE; Brandes A; Eiskjær H; Thøgersen AM; Philbert BT; Svendsen JH; Dixen U Europace; 2021 Apr; 23(4):587-595. PubMed ID: 33257933 [TBL] [Abstract][Full Text] [Related]
19. Right Ventricular Function at Cardiac MRI Predicts Cardiovascular Events in Patients with an Implantable Cardioverter-Defibrillator. Jimenez-Juan L; Ben-Dov N; Goncalves Frazao CV; Tan NS; Singh SM; Dorian P; Angaran P; Oikonomou A; Kha LT; Roifman I; Chacko B; Connelly KA; Kirpalani A; Deva D; Yan AT Radiology; 2021 Nov; 301(2):322-329. PubMed ID: 34402663 [TBL] [Abstract][Full Text] [Related]
20. Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy. El Moheb M; Nicolas J; Khamis AM; Iskandarani G; Akl EA; Refaat M Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012738. PubMed ID: 30537022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]